Company news
Genvor Incorporated (OTC:GNVR) news
Genvor Incorporated news releases on 6ix. Latest, Jul 27, 2026: Genvor’s Antimicrobial Peptides Advance into Sugar Beet Research
Press releases & updates
Genvor’s Antimicrobial Peptides Advance into Sugar Beet Research
July 27, 2026
Genvor Appoints Donald Kalkofen as Chief Financial Officer
May 21, 2026
Genvor Announces Strategic Memorandum of Understanding with Canlab International(TM) to Advance Peptide Pipeline
April 17, 2026
Genvor Announces Strategic Memorandum of Understanding with Canlab International™ to Advance Commercial Peptide Pipeline
April 14, 2026
Genvor to Present at Centri Capital Conference on April 14
April 7, 2026
Genvor, Inc. Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026
March 5, 2026
Genvor Announces Strategic Expansion into Health and Wellness Market, Leveraging Proprietary AI-Accelerated BioCypher Platform to Develop Consumer Peptide Solutions
March 4, 2026
Genvor’s AGM182 Antifungal Peptide Technology Validated in Peer-Reviewed Publication in PhytoFrontiers™
February 11, 2026
Genvor Appoints Dr. George Stavrides as Executive Vice President, Business Development & Commercialization
January 28, 2026
DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event
January 23, 2026
Genvor, Inc. to Present at the 3rd Annual DealFlow Discovery Conference
January 20, 2026
Genvor to Present at the Life Sciences Virtual Investor Forum December 11th
December 4, 2025
Genvor to Present at the Life Sciences Virtual Investor Forum December 11th
December 4, 2025
Genvor and Tuskegee University Announce Teaming Agreement to Advance Peptide Research and Sustainable Crop Protection Technologies
December 2, 2025
Genvor Inc. Partners With B2i Digital as Featured Company to Expand Investor Awareness
November 26, 2025
OTC Markets Group Welcomes New OTCQB Companies - November 17
November 16, 2025
Genvor Announces Issuance of New U.S. Patent for Corn with Antifungal Peptide
November 12, 2025
Genvor Restores Trading Status and Expands Global Collaborative Research Network
October 9, 2025
Genvor to Unveil Latest Research on Patented Peptides for Aflatoxin Resistance in Corn at BioAgTech World Congress
April 21, 2024
Genvor to Participate in BioAgTech World Congress in Raleigh, North Carolina
April 1, 2024
Genvor to Participate in World Agri-Tech Innovation Summit in San Francisco
February 26, 2024
Genvor to Attend BioSolutions Conference & Expo in Visalia, California
February 19, 2024
Genvor Provides Fiscal First Quarter 2024 Corporate Update
February 14, 2024
Genvor Appoints Veteran Agribusiness Leader Chad Pawlak as Chief Executive Officer
January 16, 2024
USDA and Genvor Scientists Publish Research Highlighting Broad-Spectrum Efficacy of Genvor’s Antimicrobial Peptides
December 17, 2023
Genvor Begins Trading on the OTCQB Venture Market
December 4, 2023
Genvor Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
November 5, 2023
OTC Markets Group Welcomes New OTCQB Companies – September 11
September 11, 2023